🎯 check Neratinib (HKI-272) product page
Neratinib (HKI-272) is a potent, irreversible pan-HER and MST1 inhibitor. It affects EGFR/HER2, PI3K/AKT, and MAPK signaling by irreversibly binding to HER kinases and blocking downstream pathways, effectively inhibiting cancer cell proliferation and inducing apoptosis.